Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Health Creates Clinical Genetics Subsidiary Called InVitae

NEW YORK (GenomeWeb News) – Genomic Health has established a wholly owned subsidiary focused on providing clinical genetic services to doctors and patients.

In its Form 10-K dated March 14 and filed with the US Securities and Exchange Commission, the Redwood City, Calif.-based firm said the subsidiary, created earlier this month, is called InVitae and will begin offering services in 2013.

"The new subsidiary is expected to focus on accelerating the integration of the human genome into medical practice with an emphasis on bioinformatics and clinical utility beyond our core business of oncology," Genomic Health said in its document. Services and programs offered may include targeted genetic test panels, whole genome sequencing, and information management services.

The services would be provided by physicians "as a component of patient management," the firm added.

Genomic Health first announced the creation of the subsidiary last month in conjunction with its fourth-quarter financial results. Randy Scott is InVitae's CEO and he remains a board member of Genomic Health.

"Investments we have made over the past several years in the development of a robust next-generation sequencing platform and the capabilities we have established in building a successful cancer genomic business make this the ideal time for Genomic Health to expand into both common and rare genetic conditions," Scott said on a conference call last month.

InVitae will offer services not products, but Genomic Health President and CEO Kim Popovits said on the call that it is not a CLIA laboratory.

The company has said it plans to invest up to $20 million into InVitae during the next two years.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.